Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by newGuy01on Jan 27, 2014 2:21pm

99 Views

Post# 22138879

RE:RE:RE:RE:RE:Gord exercises 150k of 15 cent warrants

Burcon, ask yourself this. If Gord is indeed restricted given the timing to experation of these warrants and were trading at 10cps, then why exercise warrants at 15cps when hes off restriction in less than 5 days and can then add 150k shares to his coffers at a lower price. It adds up to being a message to shareholders on the near term potential. Nothing more and nothing less.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity